Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate vs Risedronate in Postmenopausal Osteoporosis (FACT)
NCT00092014Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Sep 2002
- Primary completion
- Apr 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of alendronate in postmenopausal osteoporosis, sponsored by Organon & Co.. Started Sep 2002; status: completed.
02
Drugs
alendronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00092014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092014.